Kishiwada, Japan

Noriyuki Okujo

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Toyama Chemical Co., Ltd.. Active years: 2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Noriyuki Okujo. Retrieved from https://idiyas.com/inventor/noriyuki-okujo-gdbbpah7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0



Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Noriyuki Okujo: Innovator in Antifungal Agents

Introduction

Noriyuki Okujo is a notable inventor based in Kishiwada, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antifungal agents. His work is characterized by a focus on safety and efficacy in drug design.

Latest Patents

Noriyuki Okujo holds 1 patent for an arylamidine derivative or salt thereof. This innovative compound exhibits excellent antifungal action and high safety, making it a valuable addition to the arsenal of antifungal agents. The patent describes a general formula that includes various groups, ensuring good pharmacokinetics and pharmacodynamic properties.

Career Highlights

Okujo is associated with Toyama Chemical Co., Ltd., where he has been instrumental in advancing research and development in antifungal medications. His expertise in medicinal chemistry has led to breakthroughs that enhance the effectiveness of treatments for fungal infections.

Collaborations

Throughout his career, Noriyuki Okujo has collaborated with esteemed colleagues such as Kazuya Hayashi and Katsuji Ojima. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Noriyuki Okujo's contributions to the field of antifungal agents highlight his dedication to improving public health through innovative pharmaceutical solutions. His work continues to influence the development of effective treatments for fungal infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…